Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioIntegrate LLC is a biotechnology company specializing in regenerative medicine and the development of novel biologic therapies derived from birth tissues. The company's primary focus is on umbilical cord-derived Wharton's jelly (UC-WJ), which is rich in mesenchymal stem cells, growth factors, and cytokines. BioIntegrate's lead product, GeneXSTEM, is being evaluated in clinical trials for the treatment of knee osteoarthritis and erectile dysfunction. The company aims to provide minimally invasive, cell-based solutions to address unmet needs in orthopedics and sexual health. BioIntegrate operates primarily in the United States, with research and clinical activities centered in New York and Georgia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio Integrates.